Niacin Extended-Release Tablets Recalled for Manufacturing Microbial Contamination
Sun Pharmaceutical recalls 6,552 bottles of Niacin Extended-Release Tablets (1000mg) nationwide due to microbial contamination in manufacturing equipment. No illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for Good Manufacturing Practice deviations involving unidentified microbial contamination in manufacturing equipment. Although no specific pathogen is identified and no illnesses have been reported, the contamination represents a material risk of harm consistent with the FDA's Class II serious-health-consequences classification.
Plain-English summary
Sun Pharmaceutical Industries, Inc. is recalling 6,552 bottles of Niacin Extended-Release Tablets, USP 1000mg (Rx Only), distributed nationwide in the United States. The affected product is manufactured by Sun Pharmaceutical Industries Limited in India and distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, New Jersey.
The U.S. Food and Drug Administration (FDA) classified this as a Class II recall after discovering Good Manufacturing Practice (CGMP) deviations at the manufacturing facility. Specifically, microbial contamination was identified in stagnant water within a duct of the manufacturing equipment used to produce these tablets.
The affected product can be identified by Lot #DNE0788A with an expiration date of 07/31/2025 and National Drug Code (NDC) 47335-613-81. The lot was distributed nationwide to pharmacies and other distributors. No illnesses or injuries related to this product have been reported as of the recall announcement.
The recalled product
- Product
- NIACIN (NIACIN)
- Brand
- NIACIN
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Drug — Oral Prescription
- Hazard
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: DNE0788A Exp. 07/31/2025
UPCs (3)
- 0347335613810
- 0347335614817
- 0347335539813
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · NIACIN
- HighNiacin Extended-Release Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2025-11-26
- ModeratePrescription Niacin Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2025-10-29
- ModeratePrescription Niacin Tablets Recalled for Microbial Contamination
FDA (Drugs) · 2024-01-31
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27